Cardiac POCUS for COVID-19 patient management
Empowering frontline healthcare providers
What we’ve learned from our clinical partners
- Hospitals are preparing for, or already facing, high influxes of patients in need of urgent cardiac assessments. Leading medical societies are calling for echocardiography to be used for patient evaluation and monitoring.
- Hospital space is in short supply as institutions ramp up isolation wards. Staff are also a limited resource as many begin to fall sick.
- Echo labs are planning to train ICU attendings, PAs, and nurses who are already interacting with patients to perform focused echo exams in order to reduce exposure to sonographers and limit virus transmission through the hospital. This need has been compounded by a critical shortage of PPE.
How Caption AI can help
FDA Expedites Clearance of Caption Guidance to Aid Frontline Healthcare Workers in Fight Against COVID-19 Pandemic
In response to the growing body of evidence demonstrating the impact of COVID-19 on the heart, the U.S. Food and Drug Administration (FDA) has expedited clearance of a Caption AI software update. Following a review of just 25 days (faster than 99% of FDA clearances since 2015), the FDA cleared an updated version of Caption Guidance™—the first and only AI-guided medical imaging acquisition system.
Additionally, an updated version of Caption Interpretation™ has been made available following a recent policy announcement by the FDA aimed at increasing the availability and capability of imaging products needed for diagnosis and treatment of COVID-19 patients. Under this policy, Caption AI is the first software that incorporates the parasternal long-axis (PLAX) view into its calculation of EF—a view readily acquired at the point of care by frontline providers.
Cardiac implications of COVID-19
and the role of POCUS
According to guidance from the American College of Cardiology:
- Patients with underlying cardiovascular disease are at higher risk of contracting COVID-19 and have a worse prognosis.
- Acute cardiac complications of COVID-19 include arrhythmia and acute cardiac injury, in addition to other COVID-19 complications. Published and anecdotal reports indicate cases of acute onset heart failure, myocardial infarction, myocarditis, and cardiac arrest.
- Echocardiography is recommended for patients demonstrating heart failure, arrhythmia, ECG changes, or cardiomegaly.
Imaging’s Role in COVID-19: A conversation among colleagues
Get a first-hand look at the role of echocardiography in the fight against COVID-19. Access the replay of our recent webinar, moderated by Dr. Randolph Martin (Chief Medical Officer of Caption Health) with leading experts in critical care medicine and cardiology.
Caption AI has flattened the learning curve.
American College of Cardiology (ACC)
◌ COVID-19 Clinical Guidance For the Cardiovascular Care Team
- American Society of Echocardiography (ASE)
◌ ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak
◌ ASE Statement on Point-of-Care Ultrasound (POCUS) During the 2019 Novel Coronavirus Pandemic
◌ Recommendations for Echocardiography Laboratories Participating in Cardiac Point of Care Cardiac Ultrasound (POCUS) and Critical Care Echocardiography Training: Report from the American Society of Echocardiography
- Zheng, Y., Ma, Y., Zhang, J. et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol 17, 259–260 (2020). doi.org/10.1038/s41569-020-0360-5
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (2020); 395: 1054–62. Published online March 9, 2020. doi.org/10.1016/S0140-6736(20)30566-3
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol (2020). doi.org/10.1016/j.jacc.2020.03.031.
- Clerkin KJ, Fried JA, Raikhelkar J, et al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation (2020); 10.1161/CIRCULATIONAHA.120.046941.
- Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0950.
- Yang C, Jin Z. An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases. JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0934
- Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1017